A major Swiss study found that colorectal cancer is becoming increasingly common in adults under 50, even as rates decline in older age groups.
Researchers in Switzerland have identified a concerning trend: while colorectal cancer rates are declining among older adults, the disease is becoming increasingly common in younger people, including some in their thirties. Drawing on four decades of cancer data, the first nationwide study of its kind in Switzerland found a steady rise in cases among adults under 50. The findings, published in the European Journal of Cancer, also show that younger patients are often diagnosed at later stages, underscoring the need for greater awareness of symptoms and risk factors.
Colorectal Cancer Remains a Major Global Health Threat
Colorectal cancer is one of the most common cancers worldwide. It ranks third in new diagnoses and second in cancer-related deaths. According to the World Health Organization, more than 1.9 million people were diagnosed with the disease in 2022, and nearly 900,000 died from it.
The highest rates of colorectal cancer are seen in Europe, Australia, and New Zealand, while Eastern Europe experiences the highest mortality rates.
Switzerland reflects this broader burden. The disease is among the country’s three most frequently diagnosed cancers, with about 4,500 new cases reported each year. Although screening programs have helped reduce diagnoses in adults over 50, researchers say the opposite trend is emerging among younger age groups. Similar increases have been reported in many high-income countries.
“Cases are now emerging in people in their thirties, with no personal or family history of the disease. These patients are often diagnosed late, by which time metastases are already present,” explains Dr. Jeremy Meyer, privat-docent in the Department of Surgery at the UNIGE Faculty of Medicine and a Senior Consultant Surgeon in the Division of Digestive Surgery at the HUG.
National Study Tracks Rising Cancer Rates Under 50
To better understand the trend, Meyer teamed up with Dr. Evelyne Fournier, an epidemiologist at the Geneva Cancer Registry at UNIGE. Together, they conducted the first national study on colorectal cancer among younger adults in Switzerland.
The analysis examined 96,410 colorectal cancer cases diagnosed between 1980 and 2021. The information came from the Geneva registry and the National Agency for Cancer Registration, which collects and analyzes data from cancer registries across Switzerland’s cantons.
The researchers found that cancers diagnosed before age 50 accounted for 6.1% of all colorectal cancer cases. Within this younger population, incidence increased by about 0.5% each year, reaching nearly 7 cases per 100,000 person-years.
That pattern stands in stark contrast to what was observed among adults aged 50-74, the group most commonly targeted by screening programs. In that population, incidence declined by 1.7% among men and 2.8% among women.
Certain Types of Colon and Rectal Cancer Driving the Increase
“Our study also shows that the observed increase primarily concerns rectal cancers in both men and women, as well as right-sided colon cancers in young women. These differences suggest the presence of distinct biological or environmental mechanisms,” says Evelyne Fournier.
The study also found that younger patients were more likely to have advanced disease when diagnosed. Nearly 28% of people under 50 had metastatic cancer at the time of diagnosis, compared with about 20% of older patients.
Earlier Screening and Symptom Awareness
The researchers say recognizing warning signs could play an important role in improving outcomes. Symptoms such as persistent abdominal pain, blood in the stool, changes in bowel habits, and unexplained weight loss should not be dismissed and should prompt a medical evaluation.
“Some countries, such as the United States, have chosen to lower the screening starting age to 45. In cases of increased familial risk or hereditary colorectal cancer, screening should be carried out even earlier,” says Jeremy Meyer.
Scientists are still working to determine why colorectal cancer is becoming more common among younger adults. Several factors may be contributing, including changes in diet and lifestyle, rising obesity rates, and environmental exposures early in life that may affect the microbiome. However, researchers say no single explanation currently accounts for the increase.
Reference: “Rising early-onset colorectal cancer in Switzerland despite declining incidence in older adults: A nationwide population-based study, 1980–2021” by Evelyne Fournier, Robin Schaffar, Katharina Staehelin, Nine Rouxel, Frédéric Ris, Christian Toso, Jean-Louis Frossard, Elisabetta Rapiti, Thibaud Koessler, Lea Wildisen and Jeremy Meyer, 30 March 2026, European Journal of Cancer.
DOI: 10.1016/j.ejca.2026.116707
News – Curated by Amanda Scott, Alias Group Creative
Follow her on Bluesky
FDA Clears First-of-Its-Kind Nonmedication Treatment for PTSD
The FDA has cleared a system that uses brain activity data to personalize magnetic stimulation for PTSD, adding a new nonmedication treatment option. Every day in the United States, approximately 17.5 veterans die by suicide, [...]
FDA approves breakthrough drug to treat advanced pancreatic cancer
The Food and Drug Administration (FDA) approved on Wednesday a drug that could extend the survival of those with metastatic pancreatic cancer. The drug, called daraxonrasib, will be sold under the brand name Rasonque [...]
AI Decodes a Hidden DNA Signal Linked to Disease-Causing Mutations
Machine learning identifies the likely “initiator” and enables new predictions about DNA mutations that can cause disease. Every human cell depends on tens of thousands of genes being switched on at the right time [...]
Pope Leo Urges Global Response to Congo’s Deadliest Ebola Outbreak
Pope Leo called for international action to address the Ebola outbreak in the Democratic Republic of Congo. The epidemic has claimed over 2,500 lives and is the nation's largest recorded outbreak. The Pope emphasized [...]
Is there a summer COVID-19 surge this year? Yep, it’s ramping up again
Hantavirus. Ebola. West Nile. Measles. And, of course, cyclospora — that stomach parasite making people miserable across the country. Americans have plenty to worry about this summer. But remember COVID-19? It may not be [...]
Natural Compound in Broccoli Could Help Treat a Rare, Incurable Neurological Disease
Swinburne researchers have discovered how broccoli could help treat an extremely rare and incurable disease that affects only about 200 Australians. A naturally occurring compound in broccoli is being investigated as a possible treatment [...]
Antibody recycling, FcRn and the next generation of biologics
FcRn plays a central role in regulating the half-life of IgG antibodies and albumin, making it a critical target in both antibody engineering and autoimmune disease therapy. This article explores the biology of FcRn, [...]
Ebola kills 2,300 in three months with no vaccine available for Congo’s deadliest ever outbreak
It’s Congo’s 17th outbreak, with a toll that has eclipsed that of the country’s 2018-2020 outbreak when 2,299 deaths out of 3,481 cases were recorded. The latest data shows 101 new cases and 33 [...]
Beyond an Agency: How AI, Creativity and Commercialization Are Converging Into a New Growth Model
At a moment when AI is forcing a fundamental rethink of how work gets done, the life sciences industry is grappling with a deeper question: what role should human creativity play in an increasingly [...]
New $60 Blood Test Detects Lung Cancer Without Costly DNA Sequencing
A simple blood test that detects chemical changes in DNA identified more than 90% of stage 2-4 lung cancers in an early study, without relying on costly DNA sequencing. Researchers at Tel Aviv University and collaborating [...]
Reducing drug development failures with human-relevant models and AI
Professor Joseph C. Wu of Stanford University explains how stem cells, human-relevant models and AI are helping researchers predict which drug candidates are most likely to succeed before clinical trials. Researchers now have access [...]
Half of vaccines are binned – ‘fridge-free’ versions could change that
Vaccines that do not need to be kept cool in a fridge have been successfully trialed in patients for the first time, say UK scientists. Currently, most vaccines need to be refrigerated or frozen [...]
Mushroom Mystery: The Fungus That Makes People See Tiny Humans
A mushroom sold in markets and served in restaurants in Southwest China has an unusual warning attached to it: cook it thoroughly, or you may start seeing tiny people. For decades, people have reported [...]
Artificial intelligence used to design brand new viruses
Artificial Intelligence has been used to design brand new viruses that are fully functional and can replicate in the laboratory, say US researchers. It is the first time whole genomes have been successfully designed [...]
Molecular Manufacturing: The Future of Nanomedicine – New book from NanoappsMedical Inc.
This book explores the revolutionary potential of atomically precise manufacturing technologies to transform global healthcare, as well as practically every other sector across society. This forward-thinking volume examines how envisaged Factory@Home systems might enable the cost-effective [...]
Moderna kicks off Phase I Ebola trial as Africa readies itself for research
If the Phase I trial is successful, Moderna plans to quickly initiate Phase II and Phase III trials of its Ebola vaccine. Moderna has initiated a Phase I trial of its mRNA Ebola vaccine [...]















